Shape the future of rehabilitation
We train and mentor professionals - scientists - to conduct research in health and rehabilitation-related fields and who want to develop their clinical research skills. In our PhD program, join outstanding clinicians, engineers and other masters prepared individuals working to find new ways to improve the lives of patients and make a contribution to rehabilitation science.
Become an outstanding rehabilitation scientist working to find new ways to improve the lives of patients. Our PhD program prepares you to conduct high-quality rehabilitation research in academic, research, and/or healthcare settings.
One of fewer than 20 such programs in the country, the MGH Institute program provides students the opportunity to work with internationally renowned experts in the heart of the U.S. medical community.
A hallmark of the program is the interdisciplinary composition of its faculty, curriculum, and student body. Students come from a mix of rehabilitation-related disciplines, including but not limited to physical therapy, occupational therapy, speech-language pathology, rehabilitation nursing, and/or physiatry/rehabilitation medicine.
Careers & Outcomes
Graduates from the program are well prepared to pursue a research-oriented career in academic, research, and/or healthcare settings. Advanced research training can result in greater long-term earnings according to a study of Physical Therapists.
Our Executive Committee
Our interdisciplinary faculty includes leaders in rehabilitation from the MGH Institute’s academic disciplines, as well as those at Harvard Medical School, MIT, Mass General Brigham (Brigham and Women's, Massachusetts General, and Spaulding Rehabilitation hospitals), and other prestigious Boston-area institutions.
Latest in Rehabilitation Sciences
New SHRS Dean Looks to Advance IHP’s Mission
Pitching Biomechanics for the Red Sox
Eric Roseen, PhD
Carla Tierney-Hendricks, PhD, MS, CCC-SLP
Kristen Nunn, PhD, MS, CCC-SLP
New Research Establishes Rate of ALS Speech Decline
Teresa Kimberley Plays Key Role in New FDA-Approved Tech Offering Stroke Patients New Hope